TCR2 Therapeutics Inc.
TCRRDelisted Jun 1, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750019
TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.
Holders of 5% or more of TCRR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of TCR2 Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of TCR2 Therapeutics Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
15 Schedule 13D and 13G filings on TCR2 Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2024 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| May 5, 2023 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | K2 Principal Fund, L.P. | 13G/AOld format | – | – | – | SEC |
| Sep 1, 2022 | K2 Principal Fund, L.P. | 13GOld format | – | New | – | SEC |
| Jul 8, 20224:57 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Mar 4, 2022 | Tang Capital Partners LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Redmile Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20224:41 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Nov 10, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | ArrowMark Colorado Holdings LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Redmile Group, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Upnorth Investment Ltd | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20212:56 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Jan 11, 2021 | Wellington Management Group LLP | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell TCR2 Therapeutics Inc. shares.
No Form 144 notices for TCR2 Therapeutics Inc. are on file.